High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
JAMA, 2025 · Multicenter Bayesian noninferiority RCT with dynamic borrowing across five phenotypes
What the trial found
39% versus 38% overall; prespecified noninferiority met in four of five groups, not the immunocompromised group.
Clinical interpretation
A wide noninferiority margin, cross-phenotype borrowing and differing sensitivity analyses limit subgroup conclusions. Does not establish interchangeable support for every acidotic COPD patient or a mortality benefit.
Pathophysiologic mechanisms (shunt vs V/Q mismatch), dynamic ROX index trajectories, P-SILI prevention, and evidence-based oxygen escalation ladders.
Mechanism-based diagnosis of acute and acute-on-chronic hypercapnia, controlled oxygen, NIV, invasive ventilation, auto-PEEP troubleshooting, neuromuscular monitoring, and post-acute planning.
Pathophysiology of acute-on-chronic hypercapnia, controlled oxygen targets (88–92%), evidence-based NIV, and auto-PEEP matching mechanics.